These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 17679790)
61. [Association of metabolic syndrome components with cataract]. Bojarskiene F; Cerniauskiene LR; Paunksnis A; Luksiene DI Medicina (Kaunas); 2006; 42(2):115-22. PubMed ID: 16528127 [TBL] [Abstract][Full Text] [Related]
62. Association of metabolic risk factors with uncontrolled hypertension: comparison of the several definitions of metabolic syndrome. Cortez-Dias N; Martins SR; Belo A; Fiuza M; J Hypertens; 2013 Oct; 31(10):1991-7. PubMed ID: 23811998 [TBL] [Abstract][Full Text] [Related]
63. Comparison of four definitions of the metabolic syndrome in a Greek (Mediterranean) population. Athyros VG; Ganotakis ES; Tziomalos K; Papageorgiou AA; Anagnostis P; Griva T; Kargiotis K; Mitsiou EK; Karagiannis A; Mikhailidis DP Curr Med Res Opin; 2010 Mar; 26(3):713-9. PubMed ID: 20078335 [TBL] [Abstract][Full Text] [Related]
64. Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community. Santos AC; Barros H Diab Vasc Dis Res; 2007 Dec; 4(4):320-7. PubMed ID: 18158702 [TBL] [Abstract][Full Text] [Related]
65. Metabolic disorders and cardiovascular risk in people living with HIV/AIDS without the use of antiretroviral therapy. Raposo MA; Armiliato GNA; Guimarães NS; Caram CA; Silveira RDS; Tupinambás U Rev Soc Bras Med Trop; 2017; 50(5):598-606. PubMed ID: 29160505 [TBL] [Abstract][Full Text] [Related]
66. The prevalence of the metabolic syndrome using the National Cholesterol Educational Program and International Diabetes Federation definitions. Athyros VG; Ganotakis ES; Elisaf M; Mikhailidis DP Curr Med Res Opin; 2005 Aug; 21(8):1157-9. PubMed ID: 16083523 [TBL] [Abstract][Full Text] [Related]
67. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697 [TBL] [Abstract][Full Text] [Related]
68. The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study. Diamantopoulos EJ; Athyros VG; Yfanti GK; Migdalis EN; Elisaf M; Vardas PE; Manolis AS; Karamitsos DT; Ganotakis ES; Hatseras D; Angiology; 2005; 56(6):731-41. PubMed ID: 16327950 [TBL] [Abstract][Full Text] [Related]
69. [Analysis of the criteria used for the definition of metabolic syndrome in patients with type 2 diabetes mellitus]. Picon PX; Zanatta CM; Gerchman F; Zelmanovitz T; Gross JL; Canani LH Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):264-70. PubMed ID: 16767292 [TBL] [Abstract][Full Text] [Related]
70. Prognostic interactions between cardiovascular risk factors. Vishram JK Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126 [TBL] [Abstract][Full Text] [Related]
71. Diagnostic values of different definitions of metabolic syndrome to detect poor health status in Iranian adults without diabetes. Amiri P; Deihim T; Hosseinpanah F; Barzin M; Hasheminia M; Montazeri A; Azizi F Diabet Med; 2014 Jul; 31(7):854-61. PubMed ID: 24654736 [TBL] [Abstract][Full Text] [Related]
72. Prevalence of metabolic syndrome among staff in a Malaysian public university based on Harmonised, International Diabetes Federation and National Cholesterol Education Program Definitions. Heng KS; Hejar AR; Rushdan AZ; Loh SP Malays J Nutr; 2013 Apr; 19(1):77-86. PubMed ID: 24800386 [TBL] [Abstract][Full Text] [Related]
73. [Evaluation of diagnostic criteria for metabolic syndrome to identify insulin resistance]. Butnoriene J; Norkus A; Bunevicius R; Lasas L Medicina (Kaunas); 2006; 42(6):455-63. PubMed ID: 16816539 [TBL] [Abstract][Full Text] [Related]
74. Impact of international guidelines on the management of cardiovascular risk factors in diabetic patients with peripheral arterial disease. Margeta C; Giurgea A; Hammer A; Schlager O; Zehetmayer S; Koppensteiner R; Willfort-Ehringer A Int Angiol; 2009 Jun; 28(3):175-80. PubMed ID: 19506537 [TBL] [Abstract][Full Text] [Related]
75. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study. Halcox JP; Banegas JR; Roy C; Dallongeville J; De Backer G; Guallar E; Perk J; Hajage D; Henriksson KM; Borghi C BMC Cardiovasc Disord; 2017 Jun; 17(1):160. PubMed ID: 28623902 [TBL] [Abstract][Full Text] [Related]
76. Should all patients with metabolic syndrome be treated with statins? Abate N; Chandalia M Curr Diab Rep; 2006 Feb; 6(1):72-6. PubMed ID: 16522284 [TBL] [Abstract][Full Text] [Related]
77. Prevalence of the metabolic syndrome diagnosed using three different definitions and risk of ischemic heart disease among Kaunas adult population. Luksiene DI; Baceviciene M; Tamosiūnas A; Cerniauskiene LR; Margeviciene L; Reklaitiene R Medicina (Kaunas); 2010; 46(1):61-9. PubMed ID: 20234165 [TBL] [Abstract][Full Text] [Related]
78. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Choi KM; Kim SM; Kim YE; Choi DS; Baik SH; Lee J; Metabolism; 2007 Apr; 56(4):552-8. PubMed ID: 17379016 [TBL] [Abstract][Full Text] [Related]
79. Lipid profile parameters in Malaysian dyslipidemic patients. Al-Khateeb A; Mohamed MS; Imran K; Ibrahim S; Zilfalil BA; Yusof Z Kobe J Med Sci; 2011 Dec; 57(2):E38-48. PubMed ID: 22926072 [TBL] [Abstract][Full Text] [Related]
80. High cardiovascular risk in patients with diabetes and the cardiometabolic syndrome: mandate for statin therapy. Gonzalez GL; Manrique CM; Sowers JR J Cardiometab Syndr; 2006; 1(3):178-83. PubMed ID: 17679817 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]